User contributions
Jump to navigation
Jump to search
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 19:43, 12 September 2019 (diff | hist) (+41) Early normal tissue responses (current)
- 19:40, 12 September 2019 (diff | hist) (+40) Dose-threshold (current)
- 19:39, 12 September 2019 (diff | hist) (+40) Dose-rate effect (current)
- 19:38, 12 September 2019 (diff | hist) (+40) Dose rate effectiveness factor (current)
- 19:38, 12 September 2019 (diff | hist) (+40) Dose rate (current)
- 19:37, 12 September 2019 (diff | hist) (+40) Dose per unit intake coefficient (current)
- 19:36, 12 September 2019 (diff | hist) (+31) Dose limit (current)
- 19:35, 12 September 2019 (diff | hist) (+31) Dose criteria (current)
- 19:35, 12 September 2019 (diff | hist) (+31) Dose constraint (current)
- 19:33, 12 September 2019 (diff | hist) (+40) DNA damage signalling (current)
- 19:33, 12 September 2019 (diff | hist) (+40) Disposal (current)
- 19:32, 12 September 2019 (diff | hist) (+40) In vivo radiobioassay (current)
- 19:32, 12 September 2019 (diff | hist) (-43) Dignity
- 19:31, 12 September 2019 (diff | hist) (+40) Differentiation (current)
- 19:31, 12 September 2019 (diff | hist) (+40) Dichotomous (current)
- 19:30, 12 September 2019 (diff | hist) (+40) Diastasis (current)
- 19:30, 12 September 2019 (diff | hist) (+40) Deontological Ethics (current)
- 19:29, 12 September 2019 (diff | hist) (+40) Decontamination factor (current)
- 19:29, 12 September 2019 (diff | hist) (+41) Decontamination (current)
- 19:28, 12 September 2019 (diff | hist) (+40) Decommissioning (current)
- 19:28, 12 September 2019 (diff | hist) (+41) Decay constant (current)
- 19:26, 12 September 2019 (diff | hist) (+40) Cytokines (current)
- 19:25, 12 September 2019 (diff | hist) (+41) Curie (current)
- 19:25, 12 September 2019 (diff | hist) (+40) Coster-Kronig transition (current)
- 19:24, 12 September 2019 (diff | hist) (+40) Cost-benefit analysis (current)
- 19:23, 12 September 2019 (diff | hist) (+40) Coronary heart disease (current)
- 19:22, 12 September 2019 (diff | hist) (+31) Contamination (current)
- 19:21, 12 September 2019 (diff | hist) (+41) Constancy test (current)
- 19:21, 12 September 2019 (diff | hist) (+41) Consequential late effects (current)
- 19:21, 12 September 2019 (diff | hist) (+40) Connective tissue (current)
- 19:21, 12 September 2019 (diff | hist) (+39) Computed tomography dose index (current)
- 19:21, 12 September 2019 (diff | hist) (+40) Complex tissues (current)
- 19:20, 12 September 2019 (diff | hist) (+41) Committed equivalent dose (current)
- 19:20, 12 September 2019 (diff | hist) (+41) Committed effective dose (current)
- 19:20, 12 September 2019 (diff | hist) (+41) Colony (current)
- 19:19, 12 September 2019 (diff | hist) (+31) Co-expertise (current)
- 19:19, 12 September 2019 (diff | hist) (+40) Clonogenic survival (current)
- 19:19, 12 September 2019 (diff | hist) (+40) Clonogenic cells (current)
- 19:19, 12 September 2019 (diff | hist) (+40) Clearance level (current)
- 19:18, 12 September 2019 (diff | hist) (+40) Class SR-2 gases (current)
- 19:17, 12 September 2019 (diff | hist) (+40) Class SR-1 gases (current)
- 19:17, 12 September 2019 (diff | hist) (+40) Class SR-0 gases (current)
- 19:17, 12 September 2019 (diff | hist) (+40) Chronic exposure (current)
- 19:16, 12 September 2019 (diff | hist) (+40) Cardioverter-defibrillator (current)
- 19:16, 12 September 2019 (diff | hist) (+40) Cardiomyopathy (current)
- 19:16, 12 September 2019 (diff | hist) (+40) Cardiac valve diseases (current)
- 19:15, 12 September 2019 (diff | hist) (+40) Cardiac arrhythmias (current)
- 19:07, 12 September 2019 (diff | hist) (+40) Oversight (current)
- 19:07, 12 September 2019 (diff | hist) (+40) Orphan source (current)
- 19:07, 12 September 2019 (diff | hist) (+40) Optimisation
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
